Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6230.00 | 6156.75 | 1.0119 | 1.0130 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 5952.00 | 6156.75 | 0.9667 | 0.9632 | |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 5000.00 | 1743.19 | 5784.00 | 6156.75 | 0.9395 | 0.9326 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 5000.00 | 1743.19 | 6159.00 | 6156.75 | 1.0004 | 1.0004 |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6234.00 | 6156.75 | 1.0125 | 1.0137 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 5000.00 | 1743.19 | 4412.00 | 6156.75 | 0.7166 | 0.6655 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 5000.00 | 1743.19 | 6343.00 | 6156.75 | 1.0303 | 1.0330 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 5000.00 | 1743.19 | 3982.00 | 6156.75 | 0.6468 | 0.5742 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 5000.00 | 1743.19 | 5907.00 | 6156.75 | 0.9594 | 0.9550 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 5000.00 | 1743.19 | 6113.00 | 6156.75 | 0.9929 | 0.9922 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 5000.00 | 1743.19 | 5993.00 | 6156.75 | 0.9734 | 0.9706 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 8 | 5000.00 | 1743.19 | 6399.00 | 6156.75 | 1.0393 | 1.0429 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 5000.00 | 1743.19 | 6460.00 | 6156.75 | 1.0493 | 1.0535 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 5000.00 | 1743.19 | 5756.00 | 6156.75 | 0.9349 | 0.9274 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 5000.00 | 1743.19 | 5131.00 | 6156.75 | 0.8334 | 0.8095 |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6221.00 | 6156.75 | 1.0104 | 1.0114 | |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 5000.00 | 1743.19 | 3557.00 | 6156.75 | 0.5777 | 0.4796 |
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 5000.00 | 1743.19 | 3886.00 | 6156.75 | 0.6312 | 0.5533 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 8 | 5000.00 | 1743.19 | 5932.00 | 6156.75 | 0.9635 | 0.9596 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 8 | 5000.00 | 1743.19 | 6191.00 | 6156.75 | 1.0056 | 1.0061 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 8 | 5000.00 | 1743.19 | 4794.00 | 6156.75 | 0.7787 | 0.7432 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 8 | 5000.00 | 1743.19 | 4208.00 | 6156.75 | 0.6835 | 0.6227 |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6047.00 | 6156.75 | 0.9822 | 0.9803 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6076.00 | 6156.75 | 0.9869 | 0.9856 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 2.00 | 6156.75 | 0.0003 | -0.9757 |